Suppr超能文献

甲羟戊酸激酶缺乏症的突变谱及基因型-表型相关性

Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency.

作者信息

Mandey Saskia H L, Schneiders Marit S, Koster Janet, Waterham Hans R

机构信息

Laboratory Genetic Metabolic Diseases, Departments of Clinical Chemistry and Pediatrics, Emma Children's Hospital, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

出版信息

Hum Mutat. 2006 Aug;27(8):796-802. doi: 10.1002/humu.20361.

Abstract

Mevalonate kinase deficiency (MKD) is an autosomal recessive autoinflammatory disorder caused by mutations in the MVK gene resulting in deficient activity of mevalonate kinase (MK). Depending on the clinical severity, MKD may present as hyper-IgD and periodic fever syndrome (HIDS) or the more severe mevalonic aciduria (MA). We analyzed the MVK gene in 57 patients with MKD and found 39 different mutations including 15 novel mutations, expanding the total mutational spectrum of MKD to 63 mutations. To get more insight into the genotype-phenotype correlation in MKD, we studied the effect of selected missense mutations on MK protein stability and activity in various patient fibroblast cell lines. All MKD cell lines showed markedly decreased MK activities that correlated well with the clinical severity and, for most of the cell lines, with the amount of MK protein. When fibroblasts of MKD patients were cultured under conditions known to promote a more controlled protein folding, all cell lines of patients with the HIDS phenotype and few cell lines of patients with the MA phenotype showed an increase in the residual MK activity. This increase in enzyme activity correlates well with an increase in the MK protein levels in these cell lines, indicating that most of the mutations in MKD affect stability and/or folding of the MK protein rather than affecting the catalytic properties of the enzyme. The finding that the residual activity in MKD can be manipulated by environmental conditions may offer therapeutic options to alleviate or prevent the clinical symptoms associated with MKD.

摘要

甲羟戊酸激酶缺乏症(MKD)是一种常染色体隐性自身炎症性疾病,由MVK基因突变引起,导致甲羟戊酸激酶(MK)活性不足。根据临床严重程度,MKD可能表现为高IgD和周期性发热综合征(HIDS)或更严重的甲羟戊酸尿症(MA)。我们分析了57例MKD患者的MVK基因,发现了39种不同的突变,包括15种新突变,使MKD的总突变谱扩展到63种突变。为了更深入了解MKD的基因型-表型相关性,我们研究了特定错义突变对各种患者成纤维细胞系中MK蛋白稳定性和活性的影响。所有MKD细胞系的MK活性均显著降低,这与临床严重程度密切相关,并且对于大多数细胞系来说,与MK蛋白的量也密切相关。当在已知能促进更可控蛋白折叠的条件下培养MKD患者的成纤维细胞时,所有HIDS表型患者的细胞系和少数MA表型患者的细胞系的残余MK活性均有所增加。酶活性的这种增加与这些细胞系中MK蛋白水平的增加密切相关,表明MKD中的大多数突变影响MK蛋白的稳定性和/或折叠,而不是影响酶的催化特性。MKD中的残余活性可受环境条件调控这一发现可能为减轻或预防与MKD相关的临床症状提供治疗选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验